¾È³çÇϼ¼¿ä ö±Õ ÀÔ´Ï´Ù.
À̹ø¿¡ ¹ßÇ¥µå¸± ³í¹®ÀÇ Á¦¸ñÀº
"IFN-γ–dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis" À̸ç,
Áö³´Þ 8ÀÏ (2022.06.08), SCIENCE ADVACNES¿¡ ÃâÆÇµÈ ³í¹®ÀÔ´Ï´Ù.
¾ÏÀÇ ÀüÀÌ °úÁ¤¿¡´Â Lymphatic vesselÀÌ ÁÖ¿äÇÑ ¿µÇâÀ» ³¢Ä¡´Â ¹Ý¸é Lymphatic vessel (LV) °ú ±×¸¦ ±¸¼ºÇÏ´Â lymphatic endothelial cells (LECs)ÀÌ
Ç׿øÁ¦½Ã¿Í, CTLÀÇ ÀÛ¿ëÀÇ °üÁ¡¿¡¼ ¾î¶² »óÈ£°ü°è¸¦ °®´ÂÁö´Â À߾˷ÁÁ® ÀÖÁö ¾Ê¾Ò´Âµ¥,
º» ³í¹®Àº lymphatic vesselÀ» Àß Çü¼ºÇϵµ·Ï modified µÈ tumor model (B16F10-OVA+VC+)¸¦ ÀÌ¿ëÇÏ¿© À̸¦ Ž±¸ÇÏ¿´½À´Ï´Ù.
CTLÀÇ ±â´É¿¡ ÇʼöÀûÀÎ IFN-γÀÇ ¹ßÇöÀº ¿ÀÈ÷·Á LECsÀÇ immuno suppressive markerÀÇ ¹ßÇöÀ» ³ôÀÌ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ¾ú´Âµ¥,
ÀÌ ³í¹®¿¡¼´Â tumor ³»¿¡ ³ôÀº ¹Ðµµ·Î effector T cell ÀÌ Á¸ÀçÇÏ´Â °æ¿ì LECÀÇ apoptosis¿Í LVÀÇ Çü¼ºÀÌ ¾ïÁ¦µÇ¸ç, ÀÌ °úÁ¤Áß¿¡ tumor antigenÀÌ release µÇ¾î
Ç׿ø ƯÀÌÀûÀÎ T cellÀÇ ¹ÝÀÀÀ» Áõ´ë ½ÃÅ°¸ç ÀÌ °úÁ¤ÀÌ IFN-γ ¿¡ ÀÇÁ¸ÀûÀÓÀ» ¹àÇû½À´Ï´Ù.
Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.
ö±Õ ¿Ã¸².
³í¹® ¸µÅ© : https://www.science.org/doi/abs/10.1126/sciadv.abl5162
- ´ÙÀ½±Û
- 7/23 ¹ßÇ¥³í¹® ÀÔ´Ï´Ù
- / °ü¸®ÀÚ
-
¾È³çÇϼ¼¿ä. À̹øÁÖ ¹ßÇ¥ÀÚ ¿µÁø ÀÔ´Ï´Ù.
Á¦°¡ À̹øÁÖ Åä¿äÀÏ¿¡ ¹ßÇ¥ ÇÒ ³í¹®Àº ¿ÃÇØ JEM¿¡ ÃâÆǵÈ
"Angiotensin II enhances group 2 innate lymphoid cellresponses via AT1a during airway inflammation" ÀÔ´Ï´Ù.
ILC2´Âairway inflammationÀ» À¯¹ßÇÏ´Â Áß¿äÇÑ ¸é¿ª¼¼Æ÷ Áß Çϳª·Î ÃÖ±Ù¿¡ ÁÖ¸ñ¹Þ°í..
- ÀÌÀü±Û
- 7/16 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
- / °ü¸®ÀÚ
- ¾È³çÇϼ¼¿ä, À̹øÁÖ ¹ßÇ¥ÀÚ ´ÙÁ¤ÀÔ´Ï´Ù.
Á¦°¡ À̹ø¿¡ ¼±Á¤ÇÑ ³í¹®Àº2020³â Nature immunology¿¡ ÃâÆǵÈ
'BATF3 programs CD8+ T cell memory'ÀÔ´Ï´Ù.
¿ì¼±BATF3´Â ÀÌÀü±îÁöconventional DCÀÇdevelopment¿¡ Áß¿äÇÑ Àü»çÀÎÀڷνá Àß ¾Ë·ÁÁ® ¿Ô°í,CD8 T cell¿¡primingÀ» ½ÃÅ°´ÂCD103+ȤÀºCD8a+cDC¿¡¼ ..